Thymosin Alpha-1 (5mg)
$47.99
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally derived from the thymic protein prothymosin alpha. In research settings, Tα1 is examined for its interactions with T-cell differentiation pathways, dendritic cell activation, and innate immune signaling mechanisms in laboratory models.
BioRhex supplies Thymosin Alpha-1 as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally derived from the thymic protein prothymosin alpha. In research settings, Tα1 is examined for its interactions with T-cell differentiation pathways, dendritic cell activation, and innate immune signaling mechanisms in laboratory models.
BioRhex supplies Thymosin Alpha-1 as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
Thymosin Alpha-1 is a thymic-derived peptide studied for its immunological signaling properties. In vitro and preclinical research models examine how Tα1 may influence:
• T-cell differentiation and maturation pathway signaling
• Dendritic cell activation and antigen presentation pathway modeling
• Toll-like receptor (TLR) signaling modulation in immune cell models
• Natural killer (NK) cell activity in experimental systems
• Cytokine production and inflammatory mediator regulation
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of Thymosin Alpha-1
Thymosin Alpha-1 was first isolated and characterized by Allan Goldstein and colleagues in the 1970s during research into thymic hormones and immune system development. It was identified as the biologically active N-terminal fragment of prothymosin alpha.
Subsequent preclinical research established Tα1’s immunomodulatory signaling properties across multiple cellular and tissue models, making it a valuable tool in cellular immunology and inflammatory pathway research.
Thymosin Alpha-1 remains one of the more extensively studied immunomodulatory peptides in laboratory settings, with ongoing preclinical research into its mechanisms of action within immune signaling models.
Molecular Structure
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
Research Findings
Published and preclinical research on Thymosin Alpha-1 covers several areas of scientific investigation, including:
T-cell signaling research: Studies examine Tα1’s influence on T-helper cell differentiation and cytotoxic T-cell activation in experimental models.
Innate immune modulation: Research explores Tα1’s interactions with TLR signaling and pattern recognition receptor pathway activity.
Dendritic cell biology: Laboratory models investigate Tα1’s effects on dendritic cell maturation and antigen-presenting function.
Cytokine pathway research: Studies evaluate pro-inflammatory and anti-inflammatory cytokine production in Tα1 cellular research models.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
What type of research is Thymosin Alpha-1 used for?
What type of research is Thymosin Alpha-1 used for?
Thymosin Alpha-1 is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Where is BioRhex’s Thymosin Alpha-1 manufactured?
Where is BioRhex’s Thymosin Alpha-1 manufactured?
All BioRhex compounds, including Thymosin Alpha-1, are manufactured in a GMP-compliant facility located in the United States.
What testing does BioRhex conduct on Thymosin Alpha-1?
What testing does BioRhex conduct on Thymosin Alpha-1?
Every batch of Thymosin Alpha-1 undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Is Thymosin Alpha-1 approved for human use?
Is Thymosin Alpha-1 approved for human use?
No. Thymosin Alpha-1 is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Who should handle this compound?
Who should handle this compound?
Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. Thymosin Alpha-1 is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
